Station X
Station X is a private San Francisco software company, founded in 2010 with 11-50 employees, that builds products enabling scientists and clinicians to extract maximal biological meaning from complex genomic data.
- Company typePrivate
- Founded2010
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Station X does
Station X is a private, for-profit software company founded in 2010 and headquartered in San Francisco, United States. Per its firmographic description, the company develops software products that enable scientists and clinicians to extract maximal biological meaning from complex genomic data, positioning it in the clinical and research genomics interpretation software segment. The stated headcount band is 11-50 employees and its web presence is at stationxinc.com; no further public-facing product details, pricing, customer logos, or distribution channels are documented in the supplied source material.
Disclosed fundraising activity is concentrated in a 2011-2013 window and totals approximately $15.86M across at least six tranches, including a Series-2 close of $8.6M in November 2013, a $5.0M Series-2 led by Runa Capital in September 2012, a $1.26M Runa Capital round in July 2012, and smaller seed-stage checks in early 2012, plus a $725K Series-2 in January 2011. Runa Capital is the only named institutional investor in the dataset. The provided product, technology, customer, partnership, pricing, and operating-status fields are empty, and the bulk of scraped product/operational content pertains to Gentaur, a life-science reagent distributor, not Station X, leaving the company's actual product surface, go-to-market motion, and revenue model undocumented in the input.
Station X firmographics
Firmographics- Name
- Station X
- Website
- https://stationxinc.com
- Company type
- Private
- Founded year
- 2010
- Headcount range
- 11–50 employees
- Short description
- Station X is a private San Francisco software company, founded in 2010 with 11-50 employees, that builds products enabling scientists and clinicians to extract maximal biological meaning from complex genomic data.
- Ownership category
- akta.pro rank
Station X industry classification
Industry- Product category
- Genomic Data Analysis Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
Keywords
Where Station X is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Station X business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Station X product offering
Product offeringCore offering
Station X develops software products that enable scientists and clinicians to extract maximal biological meaning from complex genomic data. The company's tools support analysis and interpretation of genomic datasets for research and clinical applications in the life sciences.
Product overview
Gentaur offers a comprehensive portfolio of life science products focused on next-generation sequencing (NGS) and DNA sequencing. The product lineup includes NGS library preparation reagents (Multiplex PCR Master Mix variants, fragments selection reagents, cleanup reagents), quality control panels (CF Control Panels), and sequencing services (Custom DNA Sequencing, SpeedySeq). The company also provides supporting products including ELISA kits, DNA extraction kits, buffers, and electrophoresis equipment for genomics research workflows.
Differentiator
Problem solved
Functional benefit
Companies that use Station X
Customer profileIdeal customer profiles1 record
Station X technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Station X partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights2 records
Station X competitors and assessment
Company assessmentEmerging players
- Advaita Bioinformatics: Pathway and gene-set interpretation software (iPathwayGuide) for omics data, focused on biological meaning extraction from genomic analyses; overlapping interpretive workflow niche.
- Rosalind (formerly Onramp Bio): Cloud-based bioinformatics platform for multi-omic analysis aimed at researchers without deep programming backgrounds; partial overlap with Station X's mission of enabling scientists to extract biological meaning from genomic data.
- GenePattern (Broad Institute): Open-source genomic analysis platform from the Broad Institute for reproducible analyses of genomics data; a thematic peer for bioinformatics analysis software targeting scientific users.
Direct peers
- Partek (Illumina): Genomic data analysis software (Partek Flow, Partek Genomics Suite) used by scientists and clinicians for multi-omics interpretation; closely comparable on product functionality and target customer.
- DNAnexus (Velsera): Cloud-based genomic and biomedical data analysis platform serving scientists and clinicians with multi-omics interpretation workflows; directly competes with Station X in bioinformatics & multi-omics analysis software.
- Seven Bridges (now part of Velsera): Genomics and biomedical data analysis platform serving research consortia and clinical researchers; same bioinformatics/multi-omics software category as Station X.
- Qlucore: Omics data exploration and visualization software used by research scientists and clinicians to interpret complex genomic and multi-omic datasets; comparable scope and customer profile.
- Genomatix: Bioinformatics software suite for NGS data analysis and biological interpretation, with a long-standing focus on transcription factor and pathway-level analysis; directly comparable as analysis software for scientists.
Broad incumbents
- Illumina (BaseSpace): Sequencing instrument vendor with a broad genomics software portfolio including BaseSpace and DRAGEN pipelines; a larger incumbent whose analysis tools overlap with Station X's genomic interpretation focus.
- Dotmatics: Scientific R&D informatics platform with modules spanning biology, including genomic and biological data interpretation; broader incumbent whose life-science informatics footprint overlaps Station X's bioinformatics tooling.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
Station X social profiles
Digital presenceStation X financial estimates
Financial estimateRevenue estimate
Valuation estimate
Station X leadership team
Management profileNumber of profiles
Station X funding detail
Funding detailFunding overview
Funding rounds6 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Station X M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Station X
What does Station X do?
Station X develops software products that enable scientists and clinicians to extract maximal biological meaning from complex genomic data. The company's tools support analysis and interpretation of genomic datasets for research and clinical applications in the life sciences.
When was Station X founded?
Station X was founded in 2010. It employs 11 to 50 people.
Where is Station X based?
Station X is headquartered in San Francisco, United States, in the North America region.
Who are Station X's main competitors?
Emerging players on record are Advaita Bioinformatics, Rosalind (formerly Onramp Bio) and GenePattern (Broad Institute). Direct peers are Partek (Illumina), DNAnexus (Velsera), Seven Bridges (now part of Velsera), Qlucore and Genomatix. Broad incumbents are Illumina (BaseSpace) and Dotmatics.
Does Station X have an API?
No public API is recorded for Station X.
What industry is Station X in?
Station X's product category is Genomic Data Analysis Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 513210 and its SIC code is 7372.